KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Discontinued OperationsCash from Discontinued OperationsCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Change in Intangibles (2016 - 2022)

TherapeuticsMD filings provide 11 years of Change in Intangibles readings, the most recent being $95000.0 for Q4 2022.

  • On a quarterly basis, Change in Intangibles fell 93.73% to $95000.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $355000.0, a 83.78% decrease, with the full-year FY2022 number at $355000.0, down 83.78% from a year prior.
  • Change in Intangibles hit $95000.0 in Q4 2022 for TherapeuticsMD, up from -$7000.0 in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $1.5 million in Q4 2021 to a low of -$7000.0 in Q3 2022.
  • Median Change in Intangibles over the past 5 years was $309762.0 (2018), compared with a mean of $324120.4.
  • Biggest five-year swings in Change in Intangibles: skyrocketed 364.42% in 2021 and later crashed 102.78% in 2022.
  • TherapeuticsMD's Change in Intangibles stood at $356501.0 in 2018, then increased by 4.76% to $373458.0 in 2019, then decreased by 12.71% to $326000.0 in 2020, then skyrocketed by 364.42% to $1.5 million in 2021, then crashed by 93.73% to $95000.0 in 2022.
  • The last three reported values for Change in Intangibles were $95000.0 (Q4 2022), -$7000.0 (Q3 2022), and $97000.0 (Q2 2022) per Business Quant data.